Nootdorp, Netherlands

Wim Quint

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Innogenetics N.v., Innogenetics, S.a.. Active years: 2002-2012.

USPTO Granted Patents = 3 

% Patents Active = 100.0


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Wim Quint: Innovator in Hepatitis C Research

Introduction

Wim Quint, an accomplished inventor based in Nootdorp, Netherlands, has made significant contributions to the field of hepatitis C research. With a total of three patents to his name, his innovative work aims to enhance diagnostic and therapeutic approaches to this viral infection.

Latest Patents

Wim Quint's latest patents focus on previously unrecognized clades of hepatitis C virus (HCV) genotypes. One of his notable inventions, titled "HCV clade and prototype sequences thereof," relates to the applications of nucleic acids, proteins, and antibodies derived from these newly characterized hepatitis C viruses. Additionally, he holds a patent for "Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent," which introduces genomic nucleotide sequences and amino acid sequences of a new type of HCV. This invention emphasizes the potential for improved HCV detection, diagnosis, and treatment, showcasing a significant advancement in the field.

Career Highlights

Wim Quint has worked with reputable organizations, including Innogenetics, a company known for its innovative solutions in the field of molecular diagnostics and therapeutic development. His career is characterized by a commitment to advancing scientific understanding and improving health outcomes related to hepatitis C.

Collaborations

Collaboration is a vital aspect of innovation, and Wim Quint has worked alongside notable professionals, such as Leen-Jan Van Doorn and Erwin Sablon. Their combined efforts in research and development have contributed to the progress in hepatitis C diagnostics and therapeutic applications, furthering the scope of Quint's patents.

Conclusion

Wim Quint's contributions to hepatitis C research and development have not only advanced scientific understanding but have also opened new avenues for better diagnostic and therapeutic solutions. His innovative spirit and dedication continue to make an impact in the healthcare industry, highlighting the essential role of inventors in addressing global health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…